We have just published the PRAC meeting highlights: http://t.co/K7lRSRjQi6
— EMA (@EMA_News) June 14, 2013
(El Supositorio) Adiós Myolastan.... http://t.co/v7nGb1sHre #SegPac
— Sano y salvo (@sanoysalvoblog) June 16, 2013
(BMJ) Will austerity cuts dismantle the Spanish healthcare system? http://t.co/cJxndy6ies #PtSafety
— Sano y salvo (@sanoysalvoblog) June 16, 2013
Editorial BMJ: Austerity policies in Europe—bad for health http://t.co/OAJfrATbd8 #PtSafety
— Sano y salvo (@sanoysalvoblog) June 16, 2013
(BMJ) Study links poor access to GPs with greater use of emergency services http://t.co/WanPNMCqO3 #PtSafety
— Sano y salvo (@sanoysalvoblog) June 16, 2013
(NPS Medicinewise) Should you routinely test your patients for prostate cancer? http://t.co/q4aQsT8ZsG #PtSafety
— Sano y salvo (@sanoysalvoblog) June 16, 2013
(PJ online) Check for vascular events in patients using glycopyrronium http://t.co/trDMUbQRBP #PtSafety
— Sano y salvo (@sanoysalvoblog) June 16, 2013
(PJ online) EMA can assess medicines withdrawn without explanation http://t.co/qsJNffic0n
— Sano y salvo (@sanoysalvoblog) June 16, 2013
The efficiency of cardiovascular risk assessment: do the right patients get statin treatment? http://t.co/WGUSPHbYUX #PtSafety
— Sano y salvo (@sanoysalvoblog) June 16, 2013
(NICE) Falls: assessment and prevention of falls in older people http://t.co/GaqNyiQVux #PtSafety
— Sano y salvo (@sanoysalvoblog) June 16, 2013
(Lancet) Intensive insulin for type 2 diabetes: the risk of causing harm http://t.co/qBllHLCiVx #PtSafety
— Sano y salvo (@sanoysalvoblog) June 16, 2013
Sano y Salvo, de Mercedes y @JuanGrvas, un clásico que l tiempo situará en altar de imprescindibles http://t.co/UE352OIneB Por @RoberRimbaud
— Enrique Gavilán (@enriquegavilan) June 17, 2013
Riesgo aumentado fractura cadera por uso antidepresivos ancianos http://t.co/k4og8OLJVq Y mientras, usando bifosfonatos y demás #yatrogenia
— polimedlabs (@polimedlabs) June 17, 2013
8 errores de medicación que pueden cometer las mamás http://t.co/Yy2hr32cHH vía @fiebreytos #parapediatras
— Farmacia DA Oeste AP (@FarmaciaOesteAP) June 17, 2013
Caso de saturnismo asociado al consumo del producto MVV (Mahavatvidhwansa Rasa 125 mg) http://t.co/Dg6WXpa5tD
— AEMPS (@AEMPSGOB) June 17, 2013
(El Supositorio) El barreño pastillero http://t.co/5FGS8dT2ai #SegPac
— Sano y salvo (@sanoysalvoblog) June 17, 2013
RT @AEMPSGOB Diclofenaco y riesgo cardiovascular: restricciones de uso http://t.co/oLtuCyZqHT #SegPac
— Sano y salvo (@sanoysalvoblog) June 17, 2013
RT @AEMPSGOB Codeína: restricciones de uso como analgésico en pediatría http://t.co/qPQ6ZJuOQz #SegPac
— Sano y salvo (@sanoysalvoblog) June 17, 2013
(BMJ) Pressure mounts for companies to hand over data on antidiabetes drugs linked to pancreatic harm http://t.co/330MpkOn95 #PtSafety
— Sano y salvo (@sanoysalvoblog) June 17, 2013
(BMJ) Pressure mounts for companies to hand over data on antidiabetes drugs linked to pancreatic harm http://t.co/330MpkOn95 #PtSafety
— Sano y salvo (@sanoysalvoblog) June 17, 2013
Diagnostic errors harm patients. Here's a critical summary of methods for estimating their rate http://t.co/Hndxg693bT
— BMJ Quality & Safety (@BMJ_Qual_Saf) June 15, 2013
(Hemos Leído) La ADA pide una evaluación independiente de las terapias basadas en la incretina http://t.co/v1FgC8tfoL #SegPac
— Sano y salvo (@sanoysalvoblog) June 17, 2013
RT @AEMPSGOB Determinados medidores Coaguchek pueden mostrar el “error 6” en presencia de valores de INR muy elevados http://t.co/Om85WQ2NBr
— Sano y salvo (@sanoysalvoblog) June 17, 2013
Un "evento centinela" no puede pasarse por alto; la @TJCommission no sólo exige su detección sino su ACR http://t.co/0PaPpkZT0d #SegPac
— X.M. Meijome (@EnferEvidente) June 17, 2013
“@JesusmRedondo: La asociación de estatinas y macrolidos aumenta el riesgo de toxicidad en pacientes mayores http://t.co/ABnfqZ7ZMH”
— Sano y salvo (@sanoysalvoblog) June 17, 2013
Postmarket Drug Surveillance Without Trial Costs: Discovery of ADR Through Large-Scale Analysis of Web Search Queries http://t.co/1OzJTjX9Uc
— Sano y salvo (@sanoysalvoblog) June 18, 2013
Olanzapine Pamoate: Drug Safety Communication - FDA Investigating Two Deaths Following Injection http://t.co/KkxmHjDeyJ España: Zypadhera
— Sano y salvo (@sanoysalvoblog) June 18, 2013
Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men http://t.co/x8h3jglwIV #PtSafety
— Sano y salvo (@sanoysalvoblog) June 18, 2013
Adding aspirin to clopidogrel worsened outcomes in PCI patients receiving oral anticoagulants http://t.co/Pep6BvoZCu #PtSafety
— Sano y salvo (@sanoysalvoblog) June 18, 2013
Pneumonia in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist http://t.co/FSD6m4CIZo
— Sano y salvo (@sanoysalvoblog) June 20, 2013
Cinco maneras de lograr la participación de los pacientes: 1ª parte : SIN Tecnología http://t.co/djoRLw9El9 vía @rafabravo #SegPac
— Sano y salvo (@sanoysalvoblog) June 21, 2013
(El Gerente De Mediado) La austeridad mata http://t.co/yljtLmU7VP #SegPac
— Sano y salvo (@sanoysalvoblog) June 21, 2013
Publicado por Sano y salvo
No hay comentarios:
Publicar un comentario